Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, December 17, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bio-Rad Introduces Bio-Plex Pro™ Human Inflammation Panels
Tuesday, December 16, 2014
Superior profiling of cancer, cardiovascular, and other disease biomarkers.

Sysquant® Awarded Two Contracts
Monday, December 01, 2014
Proteome Sciences provide an update on SysQuant ®, its phosphorylation assay that provides insight into normal cell function, disease state and response to drug treatments in patients.

Bio-Rad Introduces System to Automate Operation of Real-Time PCR Instruments
Monday, November 03, 2014
The CFX Automation System II automates the operation of up to two CFX Real-Time PCR Detection Systems.

Bio-Rad’s New Automated Droplet Generator
Tuesday, October 28, 2014
New AutoDG™ instrument for Droplet Digital™ PCR saves time and improves data quality.

Thermo Fisher Scientific Launches Industry’s Only End-to-End, NGS Genotyping Solution for Expanded Microbial Analysis
Tuesday, October 28, 2014
Ion 16S Metagenomics Kit leverages the Ion Torrent sequencing platform and Ion Reporter for seamless assessment of mixed bacterial populations.

Horizon Discovery Group Launches Xenograft Models of Breast Cancer
Thursday, October 23, 2014
Largest available collection of PDX cell lines, faithfully modelling human breast cancers.

Bio-Rad Adds New PrimePCR™ Assays for Droplet Digital™ PCR
Wednesday, October 22, 2014
This release expands Bio-Rad’s current offering of predesigned and fully wet-lab validated assays.

Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.

OGT Launches Medical Research Exome Array at ASHG
Wednesday, October 15, 2014
Hand-curated array provides complete coverage of over 4600 medically relevant genes.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 722
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn